Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Timely zinc treatment is crucial for preventing severe complications in Acrodermatitis enteropathica.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

A family got a fungal infection from a boy who had contact with rabbits, but they all recovered with treatment.

HS needs personalized treatment plans and more research.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Upadacitinib effectively treats psoriasis and lichen planus together.

A rare genetic condition can mimic symptoms of other diseases, making diagnosis challenging.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.

A woman with rheumatoid arthritis lost all her hair during adalimumab treatment, and stopping the drug didn't help.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Hidradenitis suppurativa is linked to various diseases like obesity, depression, arthritis, and Crohn's disease, but often occurs alone.

PRP injections improve knee function better than other treatments for osteoarthritis.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disorders.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Adipose stem cell exosomes may effectively treat atopic dermatitis by reducing inflammation and improving skin health.

Triamcinolone is more effective than methotrexate for treating localized alopecia areata.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Careful management of blood thinners is crucial for lupus patients with APS.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Biosimilars lower costs but don't significantly improve access.

Pexidartinib often causes liver issues and fatigue, especially in women.

Adalimumab may cause severe hair loss in some patients.

Autogenic PRP improves graft viability more than xenogenic PRP, but both are effective.

Patients need better information about the risks of long-term steroid use.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.